States that prohibit marijuana use are experiencing significantly higher rates of adverse events related to delta-8 THC products, according to a new study published in the Journal of Medical Toxicology. Researchers from Ohio State University’s College of Medicine analyzed 4,925 incidents involving delta-8 THC reported to U.S. poison control centers …
Federal circuit court rules ‘all products’ made from federally compliant hemp are legal
The Fourth Circuit Court of Appeals ruled this week in a wrongful termination lawsuit that “all products” made from hemp that has 0.3% delta-9 THC or less are “unambiguously” federally legal. At the same time, the appellate court upheld the right of the North Carolina company to fire the worker …
Wisconsin tribes launch lobbying campaign for medical marijuana
One of the few Midwestern states remaining without legal medical or recreational marijuana, Wisconsin now has a formal political campaign dedicated to rectifying that, by lobbying state lawmakers to approve medical cannabis. And the new campaign is being spearheaded by Native American tribes, The Daily Cardinal reported. The Indigenous Cannabis …
Jazz Pharmaceuticals’ CBD drug shows promise beyond seizure reduction
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced plans to present eight abstracts at an upcoming major conference in Europe, showcasing new data on its cannabidiol (CBD) epilepsy treatment. The survey, which the company will present at the 15th European Epilepsy Congress in Rome next week, found that 87% of caregivers reported …